Specific areas of interest

09/11/2021

RunninganENDOFLIFEmedicinesreuseschemeinacarehomeorhospicesetting.pdf

09/11/2021

Interim Clinical Commissioning Policy - Remdesivir - 14 June.pdf

09/11/2021

COVID-19 Therapeutic Alert - Remdesivir - 14 June.pdf

09/11/2021

Pharmaceutical Public Link - Remdesivir - 15 June 2021.pdf

09/11/2021

Rapid Policy Statement - Palivizumab - June 2021.pdf

09/11/2021

Public Health Link - Palivizumab - June 2021.pdf

09/11/2021

Interim Clinical Commissioning Policy - IL-6 inhibitors - 14 Sep 2021.pdf

09/11/2021

Pharmaceutical Public Link - IL-6 inhibitors - 14 Sep 2021.pdf

09/11/2021

Interim Position Statement - Inhaled Budesonide - 12 April 2021.pdf

09/11/2021

Pharmaceutical Public Link - Budesonide - 13 April 2021.pdf

09/11/2021

Public Health Link - Casirivimab and imdevimab - Sep 2021.pdf

09/11/2021

Casirivimab and imdevimab hospitalised patients (4).pdf

09/11/2021

Public health Link - Astra Zeneca vaccine - 16 April 2021.pdf

09/11/2021

Public health Link - Thrombosis with thrombocytopenia following AZ vaccine - 07 May 2021 (1).pdf

09/11/2021

Public health Link - Thrombosis with thrombocytopenia following AZ vaccine - 07 May 2021.pdf

09/11/2021

Public health Link - Mitigating impact of B1.617.2 variant - 21 May 2021.pdf

09/11/2021

Public Health Link - Moderna and Pfizer-Biontech vaccine - 28 June 2021.pdf

09/11/2021

Q&A - JCVI advice of third vaccine dose for the immunosuppressed - Sep 2021.pdf

09/11/2021

Public Health Link - third vaccine dose for immunocompromised - Sep 2021 (1).pdf

15/05/2020

Ztas Covid letter[6423].pdf